PACE CLOSES $3.6 MILLION SPECIAL WARRANT FINANCING.TORONTO--(BUSINESS WIRE)--May 3, 1995--PACE CORPORATION(CANADIAN DEALING NETWORK Canadian Dealing Network (CDN)The organized OTC market of Canada. Formerly known as the Canadian Over-the-Counter Automated Trading System (COATS), the CDN became a subsidiary of the Toronto Stock Exchange in 1991. : PACL PACL Polyaluminium Chloride (water treatment) PACL Palo Alto CARET Laboratory PACL Port Access Control List PACL Power Assurance Check Left PACL Port-Based Access Control List (Cisco) PACL Port Based Acl ) The Pace Corporation today announced that it has received a receipt for its final prospectus and closed its previously announced private placement financing to raise gross proceeds of $3,615,000. Agent for the financing was Sprott Securities Ltd. Dr. Jeremy Clapp, President of Pace, said the Company is now adequately financed to permit rapid acceleration of its growth strategies for both its heart attack diagnostic tests and its lead testing products. He said the proceeds of the financing would be used (i) to complete the acquisition of all manufacturing rights for its GPBB-ELISA heart attack diagnostic; (ii) to fund clinical trials for its initial GPBB-ELISA test; (iii) to fund additional heart attack diagnostic R & D for a diverse line of products, both qualitative and quantitative including such markers as Myoglobin myoglobin (mī'əglō`bĭn), protein molecule isolated from the cells of vertebrate skeletal muscle that is both a structural and functional relative of hemoglobin, the oxygen-transport protein of the blood of higher animals. , Troponin troponin /tro·po·nin/ (tro´po-nin) a complex of muscle proteins which, when combined with Ca2+, influence tropomyosin to initiate contraction. tro·po·nin n. 1, and Creatine Kinase MB isoenzyme isoenzyme /iso·en·zyme/ (-en´zim) isozyme. i·so·en·zyme n. See isozyme. i ; (iv) to automate manufacturing of its lead testing products; (v) to fund market development of lead testing products; and (vi) working capital. Dr. Clapp said that clinical trials are expected to commence within a few weeks for the Company's GPBB-ELISA tests and that accelerated development has begun to utilize Pace patented reagents for a series of additional tests including one quantitative stat cardiac diagnostic panel of tests that could provide results in two to three minutes. The Company also reports that sales of lead test products had increased sharply in recent weeks and that further sales gains could be expected now that market development funds MDF or Market Development funds are funds given by the sale or marketing department from a vendor to help a partner to sell its products or to market its brand. Also named "coop budget" as cooperative budgets. are available. The Pace Corporation is an international company which develops, manufactures, markets and distributes easy to use, accurate and cost effective medical diagnostic and environmental test kits. Its primary areas of interest are the early differential diagnosis of heart damage, North America's number one killer, and the detection and evaluation of lead poisoning in children, the largest environmental issue in the history of the United States “American history” redirects here. For the history of the continents, see History of the Americas. The United States of America is located in the middle of the North American continent, with Canada to the north and the United Mexican States to the south. . Shares of The Pace Corporation are traded on the Canadian Dealing Network (PACL). CONTACT: The Pace Corporation Dr. Jeremy Clapp, President & C.E.O., 905/709-1196 or Kieran and Co. Inc. Jon W. Kieran or Cathy Hume, Investor Relations, 416/868-1079 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion